The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.
Bristol Myers Squibb (BMS) announced that analysis from two phase 3 trials of Zeposia (ozanimod) showed that early use of the treatment demonstrated cognitive benefits in people with relapsing multiple sclerosis
Bristol Myers Squibb has revealed two-year results from the POETYK PSO trial involving its psoriasis therapy, deucravacitinib. ... Jonathan Sadeh, senior vice president of immunology and fibrosis development at Bristol Myers Squibb, said: “Our
The Bristol Myers Squibb Foundation (BMSF), the National Medical Fellowships (NMF) and the American Association for Cancer Research (AACR) have revealed a new name for its initiative to increase clinical trial ... Commenting on Winn’s contributions,
Bristol Myers Squibb (BMS) has announced that Opdualag (nivolumab and relatlimab-rmbw) has received approval from the US Food and Drug Administration (FDA) for the treatment of adult and paediatric patients
Bristol Myers Squibb (BMS) has announced that the US Food and Drug Administration (FDA) has approved Opdivo (nivolumab) for use in combination with chemotherapy every three weeks for three cycles.
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...